ICER produced a comprehensive white paper on diagnostic testing for Alzheimer’s disease that was presented to the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC).
Date of review: January 2013
For questions, contact email@example.com.
Intervention of interest: Diagnostics for Alzheimer’s disease
Below you will find the final documents from the policy paper review process: